ArticleCureus2025
Acute Asymptomatic Pericarditis Following Olanzapine Overdose.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Olanzapine, a widely utilized atypical antipsychotic, has demonstrated substantial efficacy in managing schizophrenia and bipolar disorder, making it a cornerstone in the treatment of these conditions. Despite its therapeutic benefits, its use has been increasingly associated with adverse cardiovascular outcomes, necessitating a thorough understanding of these risks. Olanzapine is notably associated with metabolic side effects, including significant weight gain, hyperlipidemia, and hyperglycemia, which collectively predispose patients to cardiovascular disease. A rare but important adverse reaction to olanzapine overdose is acute pericarditis. While pericardial effusion with peripheral edema has been described, cases of acute pericarditis as an early manifestation remain exceedingly rare, and the underlying mechanism is poorly understood. We present the case of a male patient in his mid-30s with schizoaffective disorder who intentionally ingested approximately 300 mg of olanzapine in a suicide attempt. On presentation, he was somnolent but hemodynamically stable. Electrocardiography revealed diffuse ST-segment elevations and PR depressions consistent with acute pericarditis, despite the absence of chest pain or dyspnea. Cardiac biomarkers were normal. The patient was treated conservatively with aspirin and colchicine, with subsequent resolution of electrocardiographic changes by hospital day three. Clinicians should be vigilant for signs of acute pericarditis following olanzapine overdose, even in asymptomatic patients, as early electrocardiographic changes may be the only clue. Prompt recognition and management are crucial because untreated pericarditis can progress to complications such as cardiac tamponade or pericardial effusion, which carry a rare but real risk of cardiac arrest. This case highlights an uncommon but clinically relevant cardiovascular complication of olanzapine overdose and underscores the importance of routine cardiac monitoring in such scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.